Tech Company Financing Transactions
ARTHEx Biotech Funding Round
ARTHEx Biotech, based in Paterna, Valencia, scored $46.3 million from Columbus Venture Partners, AdBio Partners and European Innovation Council Fund.
Transaction Overview
Company Name
Announced On
5/3/2023
Transaction Type
Venture Equity
Amount
$46,293,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance its lead compound, ATX-01, an antimiR designed to target microRNA 23b (miR-23b), to a Phase I/IIa clinical trial for the treatment of Myotonic Dystrophy Type 1 (DM1).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
C/ Catedrático Agustín Escardino 9
Paterna, Valencia, 46980
SE
Paterna, Valencia, 46980
SE
Phone
Undisclosed
Website
Email Address
Overview
We are investigating antisense RNA compounds to treat diseases with unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frédéric Legros
Chief Medical Officer
Judith Walker
Chief Scientific Officer
Beatriz Llamusí
Browse more venture capital transactions:
Prev: 5/2/2023: Autonomize AI venture capital transaction
Next: 5/3/2023: hackajob venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs